Gene: SARS

6301
NEDMAS|SERRS|SERS
seryl-tRNA synthetase
protein-coding
1p13.3
Ensembl:ENSG00000031698 MIM:607529 Vega:OTTHUMG00000011726 UniprotKB:P49591
NC_000001.11
PubMed
CD|ND
1   
NA (AD)  NA (ND)   (Frontal_Cortex)
4.120e-1 (AD)  1.031e-1 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
GARS0.979
MDH20.976
DDX240.976
CIAPIN10.973
LRRC470.972
VDAC10.969
PRPF190.969
SAE10.968
PSMC10.967
PGK10.967

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
OR4F5-0.666
OR4F29-0.63
CXCR2-0.366
ASB4-0.363
MTRNR2L6-0.36
MTRNR2L9-0.355
VNN3-0.352
KLRB1-0.352
MTRNR2L10-0.351
P2RY14-0.345

Drugs/Compounds

ID Drug Name Drug Type CAS Num Status Role
DB00133SerineSmall Molecule56-45-1Approved|NutraceuticalTarget
DB00157NADHSmall Molecule58-68-4Approved|NutraceuticalTarget
DB00150L-TryptophanSmall Molecule73-22-3Approved|Nutraceutical|WithdrawnTarget
DB01831Tryptophanyl-5'ampSmall MoleculeExperimentalTarget
DB04537L-TryptophanamideSmall MoleculeExperimentalTarget
DB00135L-TyrosineSmall Molecule60-18-4Approved|Investigational|NutraceuticalTarget
DB01766Beta-(2-Naphthyl)-AlanineSmall Molecule-ExperimentalTarget
DB02709ResveratrolSmall Molecule501-36-0Approved|Experimental|InvestigationalTarget
DB03978TyrosinalSmall MoleculeExperimentalTarget
DB07205N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATESmall MoleculeExperimentalTarget
DB08371PARA-(BENZOYL)-PHENYLALANINESmall MoleculeExperimentalTarget
DB086174-(2,2,2-TRIFLUOROETHYL)-L-PHENYLALANINESmall MoleculeExperimentalTarget
DB00156L-ThreonineSmall Molecule72-19-5Approved|NutraceuticalTarget
DB00160L-AlanineSmall Molecule56-41-7Approved|NutraceuticalTarget
DB00131Adenosine monophosphateSmall Molecule61-19-8Approved|Investigational|NutraceuticalTarget
DB00171ATPSmall Molecule56-65-5Investigational|NutraceuticalTarget
DB00167L-IsoleucineSmall Molecule73-32-5Approved|Investigational|NutraceuticalTarget
DB00114Pyridoxal PhosphateSmall Molecule54-47-7Approved|Investigational|NutraceuticalTarget
DB00128L-Aspartic AcidSmall Molecule56-84-8Approved|NutraceuticalTarget
DB00142Glutamic AcidSmall Molecule56-86-0Approved|NutraceuticalTarget
DB00151L-CysteineSmall Molecule52-90-4Approved|NutraceuticalTarget
DB04299Maleic AcidSmall Molecule110-16-7ExperimentalTarget
DB09130CopperSmall Molecule7440-50-8Approved|InvestigationalTarget
DB00157NADHSmall Molecule58-68-4Approved|NutraceuticalTarget
DB034612'-Monophosphoadenosine 5'-DiphosphoriboseSmall MoleculeExperimentalTarget
DB11638ArtenimolSmall Molecule71939-50-9Approved|InvestigationalTarget
DB00174L-AsparagineSmall Molecule70-47-3Approved|Investigational|NutraceuticalTarget
DB00116Tetrahydrofolic acidSmall Molecule135-16-0NutraceuticalTarget
DB00157NADHSmall Molecule58-68-4Approved|NutraceuticalTarget
DB02358LY374571Small MoleculeExperimentalTarget
DB034612'-Monophosphoadenosine 5'-DiphosphoriboseSmall MoleculeExperimentalTarget
DB04322LY249543Small MoleculeExperimentalTarget
DB00151L-CysteineSmall Molecule52-90-4Approved|NutraceuticalTarget
DB00128L-Aspartic AcidSmall Molecule56-84-8Approved|NutraceuticalTarget
DB00117HistidineSmall Molecule71-00-1Approved|NutraceuticalTarget
DB00149L-LeucineSmall Molecule61-90-5Approved|NutraceuticalTarget
DB01169Arsenic trioxideSmall Molecule1327-53-3Approved|InvestigationalTarget
DB02338Nadph Dihydro-Nicotinamide-Adenine-DinucleotidephosphateSmall MoleculeExperimentalTarget
DB03147Flavin adenine dinucleotideSmall Molecule146-14-5ApprovedTarget
DB03566SpermidineSmall Molecule124-20-9ExperimentalTarget
DB04106FotemustineSmall Molecule-Experimental|InvestigationalTarget
DB05428motexafin gadoliniumSmall Molecule-InvestigationalTarget
DB05448PX-12Small Molecule-InvestigationalTarget
DB07740(7R,12R,13R)-13-formyl-12,14-dihydroxy-3,5,7-trimethyltetradeca-2,4-dienoic acidSmall MoleculeExperimentalTarget
ID Drug Name Action PubMed
C5768821-(2-trifluoromethoxyphenyl)-2-nitroethanone1-(2-trifluoromethoxyphenyl)-2-nitroethanone results in increased expression of SARS mRNA25596134
C5112952,2',4,4'-tetrabromodiphenyl ether"2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of SARS mRNA"19095052
C1111182',3,3',4',5-pentachloro-4-hydroxybiphenyl"2',3,3',4',5-pentachloro-4-hydroxybiphenyl affects the expression of SARS mRNA"19114083
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SARS mRNA"27188386
C517041(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II)"(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II) results in increased expression of SARS mRNA"19561079
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SARS mRNA"27188386
D000082AcetaminophenAcetaminophen results in increased expression of SARS mRNA29067470
D000082AcetaminophenAcetaminophen affects the expression of SARS mRNA17562736
D016604Aflatoxin B1Aflatoxin B1 results in decreased methylation of SARS gene27153756
C103505AM 251AM 251 results in increased expression of SARS mRNA16500647
D000643Ammonium ChlorideAmmonium Chloride affects the expression of SARS mRNA16483693
D004958Estradiol[bisphenol A co-treated with Estradiol] results in decreased expression of SARS mRNA26496021
C006780bisphenol Abisphenol A affects the expression of SARS mRNA21786754
C006780bisphenol Abisphenol A affects the expression of SARS mRNA20170705
C006780bisphenol Abisphenol A results in increased expression of SARS mRNA29275510
C006780bisphenol Abisphenol A affects the expression of SARS mRNA25181051
C006780bisphenol A[bisphenol A co-treated with Estradiol] results in decreased expression of SARS mRNA26496021
C006780bisphenol Abisphenol A results in increased methylation of SARS gene28505145
D019256Cadmium ChlorideCadmium Chloride results in increased expression of SARS protein22941245
D019256Cadmium ChlorideCadmium Chloride affects the localization of SARS protein18261755
D019256Cadmium ChlorideCadmium Chloride results in decreased expression of SARS mRNA25596134
D019256Cadmium ChlorideCadmium Chloride results in increased expression of SARS mRNA23741332
D002185CannabidiolCannabidiol results in increased expression of SARS mRNA21542829
D002220CarbamazepineCarbamazepine affects the expression of SARS mRNA24752500|2597931
D002251Carbon TetrachlorideCarbon Tetrachloride results in increased expression of SARS mRNA27339419
D020245p-Chloromercuribenzoic Acid"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SARS mRNA"27188386
C100187chloropicrinchloropicrin results in decreased expression of SARS mRNA26352163
C059262cidofovircidofovir results in increased expression of SARS mRNA25596134
D002994ClofibrateClofibrate results in decreased expression of SARS mRNA23811191
C018021cobaltous chloridecobaltous chloride results in increased expression of SARS mRNA24386269
D019327Copper SulfateCopper Sulfate results in increased expression of SARS mRNA19549813
D016572CyclosporineCyclosporine results in increased expression of SARS mRNA20106945|2163298
D016572CyclosporineCyclosporine results in increased expression of SARS mRNA25596134
D013759DronabinolDronabinol results in increased expression of SARS mRNA21542829
D003907DexamethasoneDexamethasone results in decreased expression of SARS mRNA22733784
D002945CisplatinCisplatin inhibits the reaction [Piroxicam results in decreased expression of SARS mRNA]21858171
D002945CisplatinCisplatin results in increased expression of SARS mRNA25596134
D004008DiclofenacDiclofenac affects the expression of SARS mRNA24752500
D004281Docosahexaenoic AcidsDocosahexaenoic Acids results in decreased expression of SARS mRNA16623957
D004997Ethinyl EstradiolEthinyl Estradiol results in increased expression of SARS protein20227414
D004997Ethinyl EstradiolEthinyl Estradiol affects the expression of SARS mRNA20170705|2686566
D004997Ethinyl EstradiolEthinyl Estradiol affects the expression of SARS mRNA20170705|2686566
D005020Ethyl MethanesulfonateEthyl Methanesulfonate results in increased expression of SARS mRNA23649840
D011345FenofibrateFenofibrate results in increased expression of SARS mRNA25596134
D005485FlutamideFlutamide results in increased expression of SARS mRNA24136188
D005557FormaldehydeFormaldehyde results in increased expression of SARS mRNA23649840
D019833GenisteinGenistein results in increased expression of SARS mRNA26865667
D005839GentamicinsGentamicins results in increased expression of SARS protein22061828
D005947Glucose[INS protein co-treated with Glucose] results in decreased expression of SARS mRNA22634610
D005947Glucose[INS protein co-treated with Glucose] results in increased expression of SARS mRNA22634610
D007052IbuprofenIbuprofen results in decreased expression of SARS mRNA25596134
D007069IfosfamideIfosfamide results in increased expression of SARS mRNA25596134
D007213IndomethacinIndomethacin results in increased expression of SARS mRNA17401462
D007213IndomethacinIndomethacin results in increased expression of SARS mRNA28201806
C410337K 7174K 7174 results in increased expression of SARS mRNA24086573
D007657Ketone BodiesKetone Bodies results in increased expression of SARS mRNA16807920
C045463leflunomideleflunomide results in increased expression of SARS mRNA28988120
C045463leflunomideleflunomide results in increased expression of SARS mRNA24136188
D008627Mercuric ChlorideMercuric Chloride results in increased expression of SARS mRNA16507785
D008687MetforminMetformin results in increased expression of SARS mRNA25596134
C004925methylmercuric chloridemethylmercuric chloride results in increased expression of SARS mRNA28001369
D008741Methyl MethanesulfonateMethyl Methanesulfonate results in increased expression of SARS mRNA23649840
D0156551-Methyl-4-phenylpyridinium1-Methyl-4-phenylpyridinium results in increased expression of SARS mRNA24810058
C051752nefazodonenefazodone results in increased expression of SARS mRNA24136188
C022838nickel chloridenickel chloride results in increased expression of SARS mRNA24612858
D010100OxygenOxygen deficiency results in increased expression of SARS mRNA25596134
C086401pentabromodiphenyl etherpentabromodiphenyl ether analog results in increased expression of SARS mRNA19095052
C086401pentabromodiphenyl etherpentabromodiphenyl ether results in increased expression of SARS mRNA26705709
D010416PentachlorophenolPentachlorophenol results in increased expression of SARS mRNA23892564
C023036perfluorooctanoic acidperfluorooctanoic acid results in increased expression of SARS mRNA25868421
C023036perfluorooctanoic acidperfluorooctanoic acid results in increased expression of SARS protein26879310
D010634PhenobarbitalPhenobarbital affects the expression of SARS mRNA19159669
D010705PhosgenePhosgene affects the expression of SARS mRNA16300373
D010894PiroxicamCisplatin inhibits the reaction [Piroxicam results in decreased expression of SARS mRNA]21858171
D010894PiroxicamPiroxicam results in decreased expression of SARS mRNA21858171
D011374ProgesteroneProgesterone results in increased expression of SARS mRNA18037150
C107773pterostilbenepterostilbene results in increased expression of SARS mRNA22450950
D011748PyrogallolPyrogallol results in increased expression of SARS mRNA20362636
C059514resveratrolresveratrol results in increased expression of SARS mRNA12569576
C009277sodium arsenatesodium arsenate results in increased expression of SARS mRNA16882884
C017947sodium arsenitesodium arsenite results in decreased expression of SARS mRNA28595984
C016104sodium bichromatesodium bichromate results in increased expression of SARS mRNA22561333
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of SARS mRNA21570461
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of SARS mRNA22298810
D013750TetrachloroethyleneTetrachloroethylene results in increased expression of SARS mRNA28973375
D019284ThapsigarginThapsigargin results in increased expression of SARS mRNA22378314
C013320tris(2-butoxyethyl) phosphatetris(2-butoxyethyl) phosphate results in increased expression of SARS protein24685621
D014415TunicamycinTunicamycin results in increased expression of SARS mRNA22378314
D014635Valproic AcidValproic Acid affects the expression of SARS mRNA25979313
D014635Valproic AcidValproic Acid results in increased expression of SARS mRNA23179753|2915479
D001335Vehicle EmissionsVehicle Emissions results in decreased methylation of SARS gene25560391
C025643vinclozolinvinclozolin results in decreased expression of SARS mRNA23034163
C111237vorinostatvorinostat results in decreased expression of SARS mRNA27188386

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0000978RNA polymerase II proximal promoter sequence-specific DNA binding-IDA24940000  
GO:0003723RNA binding-TAS9431993  
GO:0004828serine-tRNA ligase activity-IBA21873635  
GO:0004828serine-tRNA ligase activity-IDA24095058  
GO:0004828serine-tRNA ligase activity-TAS-  
GO:0005515protein binding-IPI26433229  
GO:0005524ATP binding-IEA-  
GO:0042803protein homodimerization activity-IPI26433229  
GO:0098619selenocysteine-tRNA ligase activity-TAS-  
GO ID GO Term Qualifier Evidence PubMed
GO:0000122negative regulation of transcription by RNA polymerase II-IDA24940000  
GO:0006351transcription, DNA-templated-IEA-  
GO:0006412translation-TAS9431993  
GO:0006418tRNA aminoacylation for protein translation-TAS-  
GO:0006434seryl-tRNA aminoacylation-IBA21873635  
GO:0006434seryl-tRNA aminoacylation-IDA24095058  
GO:0006434seryl-tRNA aminoacylation-IMP28236339  
GO:0008033tRNA processing-TAS9431993  
GO:0016259selenocysteine metabolic process-TAS-  
GO:0016525negative regulation of angiogenesis-IMP24940000  
GO:0097056selenocysteinyl-tRNA(Sec) biosynthetic process-IEA-  
GO:1904046negative regulation of vascular endothelial growth factor production-IDA24940000  
GO ID GO Term Qualifier Evidence PubMed
GO:0005634nucleus-IEA-  
GO:0005737cytoplasm-IDA28236339  
GO:0005829cytosol-IDA-  
GO:0005829cytosol-TAS-  
GO:0070062extracellular exosome-HDA20458337  23533145  
KEGG ID KEGG Term
hsa00970Aminoacyl-tRNA biosynthesis
Reactome ID Reactome Term Evidence
R-HSA-1430728MetabolismTAS
R-HSA-2408522Selenoamino acid metabolismTAS
R-HSA-2408557Selenocysteine synthesisTAS
R-HSA-379716Cytosolic tRNA aminoacylationTAS
R-HSA-379724tRNA AminoacylationTAS
R-HSA-392499Metabolism of proteinsTAS
R-HSA-71291Metabolism of amino acids and derivativesTAS
R-HSA-72766TranslationTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
11170654Structure-activity relationships at monoamine transporters and muscarinic receptors for N-substituted-3alpha-(3'-chloro-, 4'-chloro-, and 4',4''-dichloro-substituted-diphenyl)methoxytropanes. (2001 Feb 15)Newman AHJ Med Chem